

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.53851306 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.53851306 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.87614349 |
| 4 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.22859991 |
| 5 | signal peptide processing (GO:0006465) | 5.03794418 |
| 6 | * response to type I interferon (GO:0034340) | 4.90534243 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.89237126 |
| 8 | * cellular response to type I interferon (GO:0071357) | 4.85806726 |
| 9 | * type I interferon signaling pathway (GO:0060337) | 4.85806726 |
| 10 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.80761029 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.67001772 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.67001772 |
| 13 | doxorubicin metabolic process (GO:0044598) | 4.56304515 |
| 14 | daunorubicin metabolic process (GO:0044597) | 4.56304515 |
| 15 | polyketide metabolic process (GO:0030638) | 4.56304515 |
| 16 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.46661068 |
| 17 | heme biosynthetic process (GO:0006783) | 4.29332656 |
| 18 | negative regulation of interleukin-12 production (GO:0032695) | 4.18295085 |
| 19 | response to interferon-beta (GO:0035456) | 4.17537665 |
| 20 | response to interferon-alpha (GO:0035455) | 4.03451938 |
| 21 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.02001132 |
| 22 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.96157765 |
| 23 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.90420739 |
| 24 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.88957073 |
| 25 | regulation of T cell tolerance induction (GO:0002664) | 3.78270984 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.77423761 |
| 27 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.75010371 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 3.74840027 |
| 29 | macrophage activation involved in immune response (GO:0002281) | 3.74716990 |
| 30 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.69631062 |
| 31 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.69631062 |
| 32 | modulation by symbiont of host immune response (GO:0052553) | 3.69631062 |
| 33 | positive regulation by symbiont of host defense response (GO:0052509) | 3.69631062 |
| 34 | modulation by symbiont of host defense response (GO:0052031) | 3.69631062 |
| 35 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.69631062 |
| 36 | cellular response to interferon-beta (GO:0035458) | 3.65680957 |
| 37 | detection of other organism (GO:0098543) | 3.62361649 |
| 38 | erythrocyte maturation (GO:0043249) | 3.61993041 |
| 39 | detection of bacterium (GO:0016045) | 3.61962698 |
| 40 | * negative regulation of viral genome replication (GO:0045071) | 3.60549503 |
| 41 | positive regulation of type 2 immune response (GO:0002830) | 3.60376100 |
| 42 | Golgi transport vesicle coating (GO:0048200) | 3.57701363 |
| 43 | COPI coating of Golgi vesicle (GO:0048205) | 3.57701363 |
| 44 | negative regulation of T cell mediated immunity (GO:0002710) | 3.54466494 |
| 45 | positive regulation of interferon-alpha production (GO:0032727) | 3.53113663 |
| 46 | heme metabolic process (GO:0042168) | 3.53032740 |
| 47 | regulation of regulatory T cell differentiation (GO:0045589) | 3.51812307 |
| 48 | regulation of chronic inflammatory response (GO:0002676) | 3.51511389 |
| 49 | myeloid dendritic cell differentiation (GO:0043011) | 3.50757531 |
| 50 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.50654539 |
| 51 | negative T cell selection (GO:0043383) | 3.43452412 |
| 52 | regulation of RIG-I signaling pathway (GO:0039535) | 3.42791767 |
| 53 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.38209713 |
| 54 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.37643540 |
| 55 | negative thymic T cell selection (GO:0045060) | 3.37138916 |
| 56 | regulation of interferon-alpha production (GO:0032647) | 3.35420946 |
| 57 | cellular response to virus (GO:0098586) | 3.33209107 |
| 58 | leukocyte aggregation (GO:0070486) | 3.28682534 |
| 59 | tetrapyrrole biosynthetic process (GO:0033014) | 3.27763630 |
| 60 | regulation of tolerance induction (GO:0002643) | 3.25583305 |
| 61 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.25167789 |
| 62 | myeloid dendritic cell activation (GO:0001773) | 3.22806184 |
| 63 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.22561930 |
| 64 | germinal center formation (GO:0002467) | 3.22241017 |
| 65 | ribosomal small subunit assembly (GO:0000028) | 3.22147984 |
| 66 | cellular response to interleukin-15 (GO:0071350) | 3.21811309 |
| 67 | response to interleukin-15 (GO:0070672) | 3.20083533 |
| 68 | regulation of response to osmotic stress (GO:0047484) | 3.12934806 |
| 69 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.12541743 |
| 70 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.10857342 |
| 71 | porphyrin-containing compound metabolic process (GO:0006778) | 3.10437306 |
| 72 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.10322746 |
| 73 | positive thymic T cell selection (GO:0045059) | 3.08477967 |
| 74 | positive regulation of tolerance induction (GO:0002645) | 3.07825781 |
| 75 | lymphocyte chemotaxis (GO:0048247) | 3.06110799 |
| 76 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.05533604 |
| 77 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.05533604 |
| 78 | T-helper 1 type immune response (GO:0042088) | 3.04731225 |
| 79 | regulation of interleukin-12 production (GO:0032655) | 3.04576198 |
| 80 | regulation of type 2 immune response (GO:0002828) | 3.02880808 |
| 81 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.02240421 |
| 82 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.99587386 |
| 83 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.98964022 |
| 84 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.98304308 |
| 85 | erythrocyte development (GO:0048821) | 2.97751207 |
| 86 | defense response to protozoan (GO:0042832) | 2.96585831 |
| 87 | regulation of erythrocyte differentiation (GO:0045646) | 2.95560800 |
| 88 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.95075149 |
| 89 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.93694428 |
| 90 | positive regulation of humoral immune response (GO:0002922) | 2.93633198 |
| 91 | myeloid cell activation involved in immune response (GO:0002275) | 2.92535039 |
| 92 | B cell receptor signaling pathway (GO:0050853) | 2.92137688 |
| 93 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.91509634 |
| 94 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.90469978 |
| 95 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.90213518 |
| 96 | granulocyte activation (GO:0036230) | 2.89643059 |
| 97 | positive regulation of interleukin-17 production (GO:0032740) | 2.89593059 |
| 98 | response to peptidoglycan (GO:0032494) | 2.89094378 |
| 99 | positive regulation of B cell mediated immunity (GO:0002714) | 2.88933124 |
| 100 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.88933124 |
| 101 | detection of external biotic stimulus (GO:0098581) | 2.88931990 |
| 102 | positive regulation of defense response to virus by host (GO:0002230) | 2.88305854 |
| 103 | cellular response to exogenous dsRNA (GO:0071360) | 2.88137241 |
| 104 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.86513438 |
| 105 | protein targeting to ER (GO:0045047) | 2.85924070 |
| 106 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.85864162 |
| 107 | B cell mediated immunity (GO:0019724) | 2.84711671 |
| 108 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.84494988 |
| 109 | cotranslational protein targeting to membrane (GO:0006613) | 2.83055252 |
| 110 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.82420722 |
| 111 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.82392395 |
| 112 | T cell selection (GO:0045058) | 2.82374815 |
| 113 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.82181393 |
| 114 | NIK/NF-kappaB signaling (GO:0038061) | 2.81905314 |
| 115 | positive regulation of antigen processing and presentation (GO:0002579) | 2.80241722 |
| 116 | negative regulation of viral entry into host cell (GO:0046597) | 2.80217818 |
| 117 | response to protozoan (GO:0001562) | 2.74417715 |
| 118 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.71496632 |
| 119 | regulation of antigen processing and presentation (GO:0002577) | 2.71303084 |
| 120 | protein localization to endoplasmic reticulum (GO:0070972) | 2.69780505 |
| 121 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.68586366 |
| 122 | hemoglobin metabolic process (GO:0020027) | 2.68115336 |
| 123 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.64256410 |
| 124 | mature B cell differentiation involved in immune response (GO:0002313) | 2.64234466 |
| 125 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.62979104 |
| 126 | negative regulation of type I interferon production (GO:0032480) | 2.61700046 |
| 127 | * defense response to virus (GO:0051607) | 2.61130072 |
| 128 | sequestering of metal ion (GO:0051238) | 2.61011256 |
| 129 | GDP-mannose metabolic process (GO:0019673) | 2.58626528 |
| 130 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.58333873 |
| 131 | positive regulation of interferon-beta production (GO:0032728) | 2.58108425 |
| 132 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.57491990 |
| 133 | antimicrobial humoral response (GO:0019730) | 2.55793780 |
| 134 | neutrophil activation involved in immune response (GO:0002283) | 2.55667010 |
| 135 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.55095169 |
| 136 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.54081721 |
| 137 | mature B cell differentiation (GO:0002335) | 2.52148586 |
| 138 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.51539763 |
| 139 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.51448271 |
| 140 | positive regulation of isotype switching (GO:0045830) | 2.49966859 |
| 141 | interferon-gamma production (GO:0032609) | 2.49460630 |
| 142 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.49174680 |
| 143 | * regulation of viral genome replication (GO:0045069) | 2.46870251 |
| 144 | * negative regulation of viral process (GO:0048525) | 2.45874866 |
| 145 | response to interferon-gamma (GO:0034341) | 2.45709086 |
| 146 | cellular response to interferon-gamma (GO:0071346) | 2.43435553 |
| 147 | DNA deamination (GO:0045006) | 2.42957114 |
| 148 | T cell migration (GO:0072678) | 2.39612290 |
| 149 | natural killer cell activation (GO:0030101) | 2.39526820 |
| 150 | regulation of gamma-delta T cell activation (GO:0046643) | 2.38515871 |
| 151 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.37831698 |
| 152 | protein maturation by protein folding (GO:0022417) | 2.36496586 |
| 153 | definitive hemopoiesis (GO:0060216) | 2.34220798 |
| 154 | cellular response to interferon-alpha (GO:0035457) | 2.33216907 |
| 155 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.33032619 |
| 156 | regulation of defense response to virus by host (GO:0050691) | 2.32364005 |
| 157 | iron-sulfur cluster assembly (GO:0016226) | 2.31514041 |
| 158 | metallo-sulfur cluster assembly (GO:0031163) | 2.31514041 |
| 159 | protein retention in ER lumen (GO:0006621) | 2.31094486 |
| 160 | erythrocyte differentiation (GO:0030218) | 2.30597767 |
| 161 | innate immune response in mucosa (GO:0002227) | 2.30449976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.78509931 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 4.27172674 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.26697078 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.70355720 |
| 5 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.33263321 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.96839993 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.78744541 |
| 8 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.76875863 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.65453970 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.65000101 |
| 11 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.61549043 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.55755023 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.47209705 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.40689596 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.32800202 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.29973440 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.21767917 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13453052 |
| 19 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.10990445 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.06048406 |
| 21 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.03737663 |
| 22 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00293370 |
| 23 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.96103298 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.93193415 |
| 25 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89657877 |
| 26 | MYC_22102868_ChIP-Seq_BL_Human | 1.88194361 |
| 27 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.85664706 |
| 28 | * MYB_26560356_Chip-Seq_TH2_Human | 1.84522360 |
| 29 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.82994747 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.82737130 |
| 31 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.75281430 |
| 32 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.74771850 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.73651299 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.72775494 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.68364201 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.66560587 |
| 37 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.65015118 |
| 38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64533386 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.61881305 |
| 40 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.61544428 |
| 41 | * MYB_26560356_Chip-Seq_TH1_Human | 1.61028790 |
| 42 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.60606178 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59506532 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57353289 |
| 45 | GATA1_19941826_ChIP-Seq_K562_Human | 1.56131447 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.56049919 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.55794855 |
| 48 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.54670369 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.53914365 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.48784948 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48514639 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45031405 |
| 53 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43389989 |
| 54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42475262 |
| 55 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40803172 |
| 56 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.40660882 |
| 57 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37229253 |
| 58 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.34563683 |
| 59 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31039101 |
| 60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.30982794 |
| 61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29288189 |
| 62 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28555906 |
| 63 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27548614 |
| 64 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.26692346 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25322373 |
| 66 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.25027279 |
| 67 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21003229 |
| 68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20236019 |
| 69 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.19632354 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18421706 |
| 71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18192963 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17466843 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16701594 |
| 74 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.16016891 |
| 75 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14878185 |
| 76 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13511456 |
| 77 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.12250172 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11004818 |
| 79 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10267713 |
| 80 | MAF_26560356_Chip-Seq_TH2_Human | 1.09689623 |
| 81 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.07763886 |
| 82 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07256442 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07044824 |
| 84 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.06483257 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05669861 |
| 86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05125697 |
| 87 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.04889245 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04190175 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02901251 |
| 90 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02371881 |
| 91 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02216254 |
| 92 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.02153747 |
| 93 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.01843220 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01603294 |
| 95 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00948192 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00265270 |
| 97 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00079683 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99293642 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99057581 |
| 100 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98975992 |
| 101 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.98778280 |
| 102 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.98040448 |
| 103 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.97914240 |
| 104 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.96455834 |
| 105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96161225 |
| 106 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.95753458 |
| 107 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95175851 |
| 108 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.95140894 |
| 109 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94776618 |
| 110 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.93921949 |
| 111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93164022 |
| 112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93106952 |
| 113 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92522798 |
| 114 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.92416677 |
| 115 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.91315261 |
| 116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91275302 |
| 117 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90143682 |
| 118 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.88334468 |
| 119 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.87760739 |
| 120 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87331615 |
| 121 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.85901120 |
| 122 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.85520250 |
| 123 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.84949124 |
| 124 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79269067 |
| 125 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76926836 |
| 126 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.74309657 |
| 127 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.74266899 |
| 128 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.72890275 |
| 129 | P300_27268052_Chip-Seq_Bcells_Human | 0.70455250 |
| 130 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.67865881 |
| 131 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.67587225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.93486186 |
| 2 | MP0003656_abnormal_erythrocyte_physiolo | 3.58505887 |
| 3 | MP0005671_abnormal_response_to | 3.34854380 |
| 4 | MP0000685_abnormal_immune_system | 3.27429954 |
| 5 | MP0009785_altered_susceptibility_to | 3.02551411 |
| 6 | MP0005387_immune_system_phenotype | 2.80635144 |
| 7 | MP0001790_abnormal_immune_system | 2.80635144 |
| 8 | MP0003724_increased_susceptibility_to | 2.72307998 |
| 9 | MP0004147_increased_porphyrin_level | 2.62380789 |
| 10 | MP0003436_decreased_susceptibility_to | 2.58721664 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.48988655 |
| 12 | MP0005025_abnormal_response_to | 2.46338944 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.37744548 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.31579364 |
| 15 | MP0001800_abnormal_humoral_immune | 2.29561584 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.16057151 |
| 17 | MP0002723_abnormal_immune_serum | 2.14591175 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.06554942 |
| 19 | MP0003183_abnormal_peptide_metabolism | 2.02312751 |
| 20 | MP0006082_CNS_inflammation | 2.02251259 |
| 21 | MP0002398_abnormal_bone_marrow | 1.99899218 |
| 22 | MP0001819_abnormal_immune_cell | 1.96766205 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.95762160 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 1.91748266 |
| 25 | MP0001545_abnormal_hematopoietic_system | 1.91748266 |
| 26 | MP0002419_abnormal_innate_immunity | 1.81555236 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.80089454 |
| 28 | MP0002693_abnormal_pancreas_physiology | 1.78883751 |
| 29 | MP0004947_skin_inflammation | 1.78611198 |
| 30 | MP0002405_respiratory_system_inflammati | 1.75743728 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.75035895 |
| 32 | MP0000716_abnormal_immune_system | 1.72516054 |
| 33 | MP0004264_abnormal_extraembryonic_tissu | 1.72182218 |
| 34 | MP0002006_tumorigenesis | 1.69625182 |
| 35 | MP0006054_spinal_hemorrhage | 1.65393735 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.62777898 |
| 37 | MP0002429_abnormal_blood_cell | 1.62730330 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.61976629 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.60472508 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.60280808 |
| 41 | MP0005310_abnormal_salivary_gland | 1.59638579 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.58359784 |
| 43 | MP0002722_abnormal_immune_system | 1.58017235 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.57528508 |
| 45 | MP0005451_abnormal_body_composition | 1.54259048 |
| 46 | MP0000490_abnormal_crypts_of | 1.53781528 |
| 47 | MP0008469_abnormal_protein_level | 1.51435267 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.49313833 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.46801080 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.43377315 |
| 51 | MP0002132_abnormal_respiratory_system | 1.35791912 |
| 52 | MP0001853_heart_inflammation | 1.32390011 |
| 53 | MP0003186_abnormal_redox_activity | 1.31011647 |
| 54 | MP0004510_myositis | 1.31011496 |
| 55 | MP0003303_peritoneal_inflammation | 1.29073225 |
| 56 | MP0009764_decreased_sensitivity_to | 1.28916473 |
| 57 | MP0003075_altered_response_to | 1.25426895 |
| 58 | MP0003866_abnormal_defecation | 1.19475249 |
| 59 | MP0001944_abnormal_pancreas_morphology | 1.17912661 |
| 60 | MP0009840_abnormal_foam_cell | 1.15574291 |
| 61 | MP0000858_altered_metastatic_potential | 1.14438738 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 1.13621381 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.13178565 |
| 64 | MP0002933_joint_inflammation | 1.12899933 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 1.12541191 |
| 66 | MP0004043_abnormal_pH_regulation | 1.11818881 |
| 67 | MP0005166_decreased_susceptibility_to | 1.11206918 |
| 68 | MP0008004_abnormal_stomach_pH | 1.10236065 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 1.09683437 |
| 70 | MP0002332_abnormal_exercise_endurance | 1.07246580 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 1.05236028 |
| 72 | MP0005058_abnormal_lysosome_morphology | 1.04934911 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.03252878 |
| 74 | MP0000343_altered_response_to | 1.02562784 |
| 75 | MP0001986_abnormal_taste_sensitivity | 1.01113921 |
| 76 | MP0001348_abnormal_lacrimal_gland | 0.98307557 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.95953623 |
| 78 | MP0002139_abnormal_hepatobiliary_system | 0.95462955 |
| 79 | MP0005083_abnormal_biliary_tract | 0.94823572 |
| 80 | MP0001663_abnormal_digestive_system | 0.94023329 |
| 81 | MP0001873_stomach_inflammation | 0.93532474 |
| 82 | MP0004782_abnormal_surfactant_physiolog | 0.91683833 |
| 83 | MP0003448_altered_tumor_morphology | 0.91211048 |
| 84 | MP0010352_gastrointestinal_tract_polyps | 0.90858331 |
| 85 | MP0002928_abnormal_bile_duct | 0.89103104 |
| 86 | MP0008260_abnormal_autophagy | 0.88479097 |
| 87 | MP0000678_abnormal_parathyroid_gland | 0.88323707 |
| 88 | MP0003045_fibrosis | 0.88049489 |
| 89 | MP0009643_abnormal_urine_homeostasis | 0.87363174 |
| 90 | MP0002019_abnormal_tumor_incidence | 0.86659815 |
| 91 | MP0004883_abnormal_blood_vessel | 0.86274095 |
| 92 | MP0005220_abnormal_exocrine_pancreas | 0.85988324 |
| 93 | MP0000604_amyloidosis | 0.85968986 |
| 94 | MP0001851_eye_inflammation | 0.84738972 |
| 95 | MP0002998_abnormal_bone_remodeling | 0.84734573 |
| 96 | MP0005164_abnormal_response_to | 0.83225516 |
| 97 | MP0009763_increased_sensitivity_to | 0.83090687 |
| 98 | MP0001881_abnormal_mammary_gland | 0.81701781 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.80389545 |
| 100 | MP0003795_abnormal_bone_structure | 0.80280450 |
| 101 | MP0002909_abnormal_adrenal_gland | 0.80110620 |
| 102 | MP0009278_abnormal_bone_marrow | 0.77670199 |
| 103 | MP0005390_skeleton_phenotype | 0.77250140 |
| 104 | MP0003693_abnormal_embryo_hatching | 0.76659770 |
| 105 | MP0002163_abnormal_gland_morphology | 0.74841245 |
| 106 | MP0003195_calcinosis | 0.74322225 |
| 107 | MP0003191_abnormal_cellular_cholesterol | 0.74293611 |
| 108 | MP0000313_abnormal_cell_death | 0.73443780 |
| 109 | MP0002254_reproductive_system_inflammat | 0.73171669 |
| 110 | MP0004381_abnormal_hair_follicle | 0.71688915 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.71564307 |
| 112 | MP0010307_abnormal_tumor_latency | 0.71377194 |
| 113 | MP0003011_delayed_dark_adaptation | 0.69158002 |
| 114 | MP0000609_abnormal_liver_physiology | 0.68158376 |
| 115 | MP0003690_abnormal_glial_cell | 0.67603836 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.66347183 |
| 117 | MP0010386_abnormal_urinary_bladder | 0.64354970 |
| 118 | MP0003453_abnormal_keratinocyte_physiol | 0.63573550 |
| 119 | MP0000249_abnormal_blood_vessel | 0.61987909 |
| 120 | MP0008874_decreased_physiological_sensi | 0.60160428 |
| 121 | MP0001501_abnormal_sleep_pattern | 0.59822021 |
| 122 | MP0003646_muscle_fatigue | 0.55799188 |
| 123 | MP0003091_abnormal_cell_migration | 0.55078404 |
| 124 | MP0002136_abnormal_kidney_physiology | 0.53983552 |
| 125 | MP0005381_digestive/alimentary_phenotyp | 0.49385416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 6.04215867 |
| 2 | Stomatitis (HP:0010280) | 5.24825480 |
| 3 | Nasal polyposis (HP:0100582) | 4.51500078 |
| 4 | Mediastinal lymphadenopathy (HP:0100721) | 4.24574162 |
| 5 | Abnormality of the nasal mucosa (HP:0000433) | 4.13257731 |
| 6 | Keratoconjunctivitis sicca (HP:0001097) | 4.11747691 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.07291599 |
| 8 | Recurrent bronchitis (HP:0002837) | 4.02138925 |
| 9 | Chronic otitis media (HP:0000389) | 3.90654438 |
| 10 | Poikilocytosis (HP:0004447) | 3.87853180 |
| 11 | Keratoconjunctivitis (HP:0001096) | 3.84598821 |
| 12 | Encephalitis (HP:0002383) | 3.84070158 |
| 13 | Gastrointestinal infarctions (HP:0005244) | 3.31693468 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.26550671 |
| 15 | Myositis (HP:0100614) | 3.23527265 |
| 16 | Petechiae (HP:0000967) | 3.21832092 |
| 17 | Hemoptysis (HP:0002105) | 3.20281803 |
| 18 | Abnormal number of erythroid precursors (HP:0012131) | 3.12826758 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 3.11931827 |
| 20 | Obstructive lung disease (HP:0006536) | 3.11931827 |
| 21 | Type I transferrin isoform profile (HP:0003642) | 3.11506646 |
| 22 | Increased IgE level (HP:0003212) | 3.11504910 |
| 23 | Abnormality of T cell physiology (HP:0011840) | 3.10274417 |
| 24 | Bronchitis (HP:0012387) | 3.10081432 |
| 25 | Reduced antithrombin III activity (HP:0001976) | 3.09510382 |
| 26 | Hypochromic microcytic anemia (HP:0004840) | 3.09425145 |
| 27 | Gangrene (HP:0100758) | 3.07500198 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.06670108 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.01763951 |
| 30 | Lymphopenia (HP:0001888) | 2.98150801 |
| 31 | Recurrent viral infections (HP:0004429) | 2.97134347 |
| 32 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.94223221 |
| 33 | Interstitial pulmonary disease (HP:0006530) | 2.90864891 |
| 34 | Gastrointestinal stroma tumor (HP:0100723) | 2.90722130 |
| 35 | IgM deficiency (HP:0002850) | 2.90431570 |
| 36 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.86988665 |
| 37 | Thrombocytosis (HP:0001894) | 2.85424120 |
| 38 | Eosinophilia (HP:0001880) | 2.83593709 |
| 39 | Recurrent bacterial skin infections (HP:0005406) | 2.82990551 |
| 40 | Increased IgM level (HP:0003496) | 2.81989711 |
| 41 | Leukocytosis (HP:0001974) | 2.81462812 |
| 42 | Vacuolated lymphocytes (HP:0001922) | 2.78639307 |
| 43 | Microcytic anemia (HP:0001935) | 2.77533422 |
| 44 | Severe combined immunodeficiency (HP:0004430) | 2.76036301 |
| 45 | Granulocytopenia (HP:0001913) | 2.75134206 |
| 46 | Arterial thrombosis (HP:0004420) | 2.73285885 |
| 47 | Recurrent fungal infections (HP:0002841) | 2.69807510 |
| 48 | Abnormality of the pleura (HP:0002103) | 2.68721832 |
| 49 | Autoimmune thrombocytopenia (HP:0001973) | 2.67937802 |
| 50 | Anorexia (HP:0002039) | 2.66571699 |
| 51 | Osteomalacia (HP:0002749) | 2.63955512 |
| 52 | Prolonged bleeding time (HP:0003010) | 2.63538603 |
| 53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.62908442 |
| 54 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.62908442 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.61416342 |
| 56 | Abnormal protein glycosylation (HP:0012346) | 2.60154218 |
| 57 | Abnormal glycosylation (HP:0012345) | 2.60154218 |
| 58 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.60154218 |
| 59 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.60154218 |
| 60 | Abnormality of eosinophils (HP:0001879) | 2.57985358 |
| 61 | Abnormality of T cells (HP:0002843) | 2.57409047 |
| 62 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.55817345 |
| 63 | Flat capital femoral epiphysis (HP:0003370) | 2.53384590 |
| 64 | Pulmonary embolism (HP:0002204) | 2.52367550 |
| 65 | Reticulocytosis (HP:0001923) | 2.51241868 |
| 66 | Orchitis (HP:0100796) | 2.50256134 |
| 67 | Acanthocytosis (HP:0001927) | 2.49162698 |
| 68 | Chronic diarrhea (HP:0002028) | 2.48654938 |
| 69 | Chronic sinusitis (HP:0011109) | 2.48431386 |
| 70 | Hypochromic anemia (HP:0001931) | 2.44880452 |
| 71 | Agammaglobulinemia (HP:0004432) | 2.41134578 |
| 72 | Vasculitis (HP:0002633) | 2.39115091 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.35862259 |
| 74 | Chest pain (HP:0100749) | 2.35687182 |
| 75 | Abnormality of macrophages (HP:0004311) | 2.35368912 |
| 76 | Loss of speech (HP:0002371) | 2.34465339 |
| 77 | Epistaxis (HP:0000421) | 2.33918449 |
| 78 | Pustule (HP:0200039) | 2.33504103 |
| 79 | Keratitis (HP:0000491) | 2.31766155 |
| 80 | Inflammation of the large intestine (HP:0002037) | 2.31168551 |
| 81 | Aplastic anemia (HP:0001915) | 2.29768451 |
| 82 | Dysostosis multiplex (HP:0000943) | 2.29428107 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 2.29188655 |
| 84 | Polyneuropathy (HP:0001271) | 2.29174671 |
| 85 | Colitis (HP:0002583) | 2.26211437 |
| 86 | Recurrent skin infections (HP:0001581) | 2.25738831 |
| 87 | Spontaneous hematomas (HP:0007420) | 2.25394666 |
| 88 | Gastrointestinal inflammation (HP:0004386) | 2.24334997 |
| 89 | Sepsis (HP:0100806) | 2.24172032 |
| 90 | Parakeratosis (HP:0001036) | 2.24011871 |
| 91 | Abnormality of the pericardium (HP:0001697) | 2.23271626 |
| 92 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.22833184 |
| 93 | Purpura (HP:0000979) | 2.18705174 |
| 94 | Recurrent pneumonia (HP:0006532) | 2.17590945 |
| 95 | Abnormality of the intrinsic pathway (HP:0010989) | 2.17396227 |
| 96 | Poor head control (HP:0002421) | 2.14809381 |
| 97 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.14313300 |
| 98 | Arthralgia (HP:0002829) | 2.12089168 |
| 99 | Skin rash (HP:0000988) | 2.12083623 |
| 100 | Disinhibition (HP:0000734) | 2.11690485 |
| 101 | Abnormality of reticulocytes (HP:0004312) | 2.10981770 |
| 102 | Gingivitis (HP:0000230) | 2.09527182 |
| 103 | Abnormality of T cell number (HP:0011839) | 2.09200043 |
| 104 | Cellulitis (HP:0100658) | 2.08400894 |
| 105 | Glomerulopathy (HP:0100820) | 2.08339542 |
| 106 | Osteomyelitis (HP:0002754) | 2.07986256 |
| 107 | Abnormality of the prostate (HP:0008775) | 2.06341444 |
| 108 | Lymphoma (HP:0002665) | 2.06264382 |
| 109 | IgG deficiency (HP:0004315) | 2.05508377 |
| 110 | Thyroiditis (HP:0100646) | 2.05322094 |
| 111 | Verrucae (HP:0200043) | 2.05044054 |
| 112 | Papilloma (HP:0012740) | 2.05044054 |
| 113 | Meningitis (HP:0001287) | 2.04726830 |
| 114 | Basal ganglia calcification (HP:0002135) | 2.04540330 |
| 115 | T lymphocytopenia (HP:0005403) | 2.04200683 |
| 116 | Abnormality of glycolipid metabolism (HP:0010969) | 2.02374466 |
| 117 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.02374466 |
| 118 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.02374466 |
| 119 | Gingival bleeding (HP:0000225) | 2.00964668 |
| 120 | IgA deficiency (HP:0002720) | 2.00904397 |
| 121 | Increased serum ferritin (HP:0003281) | 2.00813379 |
| 122 | Urticaria (HP:0001025) | 2.00787199 |
| 123 | Periodontitis (HP:0000704) | 2.00364255 |
| 124 | Recurrent sinusitis (HP:0011108) | 2.00177206 |
| 125 | Pallor (HP:0000980) | 1.98141608 |
| 126 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96648089 |
| 127 | Mucopolysacchariduria (HP:0008155) | 1.96648089 |
| 128 | Cheilitis (HP:0100825) | 1.95729270 |
| 129 | Cutaneous photosensitivity (HP:0000992) | 1.94826048 |
| 130 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.93904283 |
| 131 | 11 pairs of ribs (HP:0000878) | 1.93839034 |
| 132 | B lymphocytopenia (HP:0010976) | 1.93373932 |
| 133 | Abnormality of B cell number (HP:0010975) | 1.93373932 |
| 134 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93033476 |
| 135 | Panhypogammaglobulinemia (HP:0003139) | 1.92843802 |
| 136 | Retrobulbar optic neuritis (HP:0100654) | 1.90703113 |
| 137 | Optic neuritis (HP:0100653) | 1.90703113 |
| 138 | Irregular vertebral endplates (HP:0003301) | 1.90677321 |
| 139 | Hyperbilirubinemia (HP:0002904) | 1.90235391 |
| 140 | Pulmonary infiltrates (HP:0002113) | 1.85122128 |
| 141 | Joint swelling (HP:0001386) | 1.83973138 |
| 142 | Combined immunodeficiency (HP:0005387) | 1.83700046 |
| 143 | Bronchiectasis (HP:0002110) | 1.83123861 |
| 144 | Diaphragmatic weakness (HP:0009113) | 1.81257143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.85923550 |
| 2 | NME2 | 3.26630660 |
| 3 | CDK12 | 2.96414400 |
| 4 | TBK1 | 2.83233135 |
| 5 | IKBKE | 2.82632324 |
| 6 | JAK3 | 2.77203487 |
| 7 | TYK2 | 2.59547740 |
| 8 | KIT | 2.59027335 |
| 9 | MAP4K1 | 2.41529679 |
| 10 | TAOK3 | 2.13477682 |
| 11 | ZAP70 | 2.04678920 |
| 12 | FLT3 | 2.01186633 |
| 13 | MAP3K14 | 1.98686920 |
| 14 | IRAK4 | 1.98381082 |
| 15 | IRAK3 | 1.95278575 |
| 16 | PRPF4B | 1.88353946 |
| 17 | MAP3K11 | 1.86925322 |
| 18 | PIM2 | 1.84572802 |
| 19 | TAOK2 | 1.84167672 |
| 20 | TGFBR2 | 1.83592018 |
| 21 | IKBKB | 1.67168663 |
| 22 | BLK | 1.66116224 |
| 23 | TLK1 | 1.65439771 |
| 24 | TXK | 1.64099007 |
| 25 | HIPK2 | 1.58348866 |
| 26 | BMPR2 | 1.56660202 |
| 27 | SIK3 | 1.54883475 |
| 28 | ADRBK2 | 1.53978405 |
| 29 | FES | 1.53839976 |
| 30 | FGFR4 | 1.53443735 |
| 31 | TESK2 | 1.51827932 |
| 32 | SYK | 1.51792142 |
| 33 | PASK | 1.51176747 |
| 34 | STK10 | 1.50855458 |
| 35 | TAOK1 | 1.50547121 |
| 36 | GRK6 | 1.49371873 |
| 37 | JAK1 | 1.42855732 |
| 38 | CSF1R | 1.41815454 |
| 39 | MAPK15 | 1.34600466 |
| 40 | FGFR3 | 1.28207819 |
| 41 | TEC | 1.24835993 |
| 42 | CHUK | 1.22822657 |
| 43 | BTK | 1.21518260 |
| 44 | PIM1 | 1.21013152 |
| 45 | FGR | 1.17568813 |
| 46 | STK4 | 1.17322770 |
| 47 | VRK1 | 1.17305781 |
| 48 | INSRR | 1.15817677 |
| 49 | RPS6KA5 | 1.15066320 |
| 50 | MATK | 1.09905541 |
| 51 | PRKG2 | 1.09310041 |
| 52 | MST4 | 1.05557838 |
| 53 | CSK | 1.03517797 |
| 54 | GRK5 | 1.01331770 |
| 55 | RPS6KA4 | 1.01005071 |
| 56 | DYRK3 | 0.98595844 |
| 57 | GRK1 | 0.98168813 |
| 58 | NLK | 0.96259034 |
| 59 | KDR | 0.93415690 |
| 60 | EPHA3 | 0.88574665 |
| 61 | LYN | 0.87412970 |
| 62 | RIPK1 | 0.87395632 |
| 63 | JAK2 | 0.85973266 |
| 64 | LCK | 0.83052488 |
| 65 | MAP3K3 | 0.80978225 |
| 66 | BRSK2 | 0.80526947 |
| 67 | SIK2 | 0.78186810 |
| 68 | MAP2K3 | 0.76767145 |
| 69 | EIF2AK1 | 0.76096651 |
| 70 | ZAK | 0.73555943 |
| 71 | CDC42BPA | 0.69871640 |
| 72 | GRK7 | 0.69052896 |
| 73 | IRAK1 | 0.68233193 |
| 74 | LRRK2 | 0.68086635 |
| 75 | EIF2AK2 | 0.67141668 |
| 76 | PIK3CG | 0.65815197 |
| 77 | IRAK2 | 0.63085735 |
| 78 | SCYL2 | 0.62237794 |
| 79 | PRKCD | 0.61477089 |
| 80 | MAPKAPK3 | 0.60632387 |
| 81 | MOS | 0.60158466 |
| 82 | DYRK1B | 0.60110025 |
| 83 | CLK1 | 0.59908575 |
| 84 | CAMKK2 | 0.58913816 |
| 85 | MAP3K5 | 0.57425401 |
| 86 | MAP3K12 | 0.57158004 |
| 87 | PDK1 | 0.55066609 |
| 88 | EIF2AK3 | 0.54256417 |
| 89 | MAPK11 | 0.54119706 |
| 90 | ABL2 | 0.53934798 |
| 91 | MAPK7 | 0.51691060 |
| 92 | HCK | 0.51561881 |
| 93 | TGFBR1 | 0.51309741 |
| 94 | SIK1 | 0.51090111 |
| 95 | PRKD2 | 0.50265838 |
| 96 | FYN | 0.48247846 |
| 97 | ITK | 0.47849923 |
| 98 | EPHB1 | 0.46698447 |
| 99 | MUSK | 0.46466893 |
| 100 | CDK7 | 0.46237697 |
| 101 | BCKDK | 0.45732725 |
| 102 | MAP3K8 | 0.44693317 |
| 103 | AURKB | 0.44466350 |
| 104 | MAPKAPK2 | 0.44452641 |
| 105 | MAP3K10 | 0.42196336 |
| 106 | TRPM7 | 0.42058594 |
| 107 | MAP2K6 | 0.41427990 |
| 108 | ACVR1B | 0.40788413 |
| 109 | MAP3K13 | 0.40206005 |
| 110 | RPS6KB2 | 0.39160738 |
| 111 | CDK9 | 0.37960592 |
| 112 | CDK4 | 0.37150205 |
| 113 | MARK3 | 0.36565507 |
| 114 | RIPK4 | 0.35534893 |
| 115 | DDR2 | 0.34433691 |
| 116 | PKN1 | 0.32940788 |
| 117 | NEK9 | 0.30689688 |
| 118 | INSR | 0.29106183 |
| 119 | PRKCQ | 0.28483085 |
| 120 | MAP3K1 | 0.28441207 |
| 121 | TNK2 | 0.27190476 |
| 122 | EGFR | 0.27019204 |
| 123 | MAPK3 | 0.26033472 |
| 124 | ABL1 | 0.24160914 |
| 125 | MAPK12 | 0.20729493 |
| 126 | CAMKK1 | 0.20235340 |
| 127 | STK24 | 0.20088363 |
| 128 | MAPK4 | 0.18416846 |
| 129 | DAPK3 | 0.18221188 |
| 130 | PTK2B | 0.16889737 |
| 131 | PDPK1 | 0.14948422 |
| 132 | RPS6KA6 | 0.14057932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.61225065 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.11308054 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.53288644 |
| 4 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.43821958 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.40117036 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.36554540 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.31485481 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.19547971 |
| 9 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.17438261 |
| 10 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.16454667 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.10349652 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07621171 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.96247873 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.94254716 |
| 15 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.86435044 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.83379254 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.83343798 |
| 18 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.82783023 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.77153063 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.72930430 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.69684589 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.67215712 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.64918013 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.57558604 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.54180979 |
| 26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.50532918 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.50249716 |
| 28 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.49730531 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.43001958 |
| 30 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.26763585 |
| 31 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26021914 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.22283238 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.21507827 |
| 34 | Asthma_Homo sapiens_hsa05310 | 1.16592313 |
| 35 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.16460922 |
| 36 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.15782830 |
| 37 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.15188180 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15184021 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.13762855 |
| 40 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.11653794 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.05707989 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.04965396 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.04163130 |
| 44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.03622871 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.03042100 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.02628006 |
| 47 | Homologous recombination_Homo sapiens_hsa03440 | 0.99112538 |
| 48 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99064550 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94056472 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.93146921 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91237542 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90791530 |
| 53 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.90353605 |
| 54 | Alcoholism_Homo sapiens_hsa05034 | 0.90008104 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.88848979 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 0.87902613 |
| 57 | Hepatitis C_Homo sapiens_hsa05160 | 0.86220775 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.85347495 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 0.83158506 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82421312 |
| 61 | Proteasome_Homo sapiens_hsa03050 | 0.79141097 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78322915 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75181692 |
| 64 | Base excision repair_Homo sapiens_hsa03410 | 0.74811298 |
| 65 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70006933 |
| 66 | Mismatch repair_Homo sapiens_hsa03430 | 0.69608022 |
| 67 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.68159094 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68119193 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66461334 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65983944 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65023267 |
| 72 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64987116 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62769105 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61797295 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59257502 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58421788 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.58032434 |
| 78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56748982 |
| 79 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55241834 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55151151 |
| 81 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.54030478 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51880543 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50264626 |
| 84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.49885894 |
| 85 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49716589 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49300800 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.47742010 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47675849 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47541765 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45891281 |
| 91 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.43119434 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42551148 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42133034 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41478228 |
| 95 | Cell cycle_Homo sapiens_hsa04110 | 0.41292366 |
| 96 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39970520 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38433666 |
| 98 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38302211 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38047592 |
| 100 | Salmonella infection_Homo sapiens_hsa05132 | 0.37588100 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36819582 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35756468 |
| 103 | Viral myocarditis_Homo sapiens_hsa05416 | 0.35395030 |
| 104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35369235 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35028800 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.33920751 |
| 107 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.33415216 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32404621 |
| 109 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.30864317 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.29211493 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28706163 |
| 112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.27963505 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25402112 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24999024 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.22803042 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.21211987 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.20528597 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.19648319 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.18098424 |
| 120 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.17594236 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17308108 |
| 122 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.13865892 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13471540 |
| 124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.13032509 |
| 125 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.12495504 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.06963139 |
| 127 | Bladder cancer_Homo sapiens_hsa05219 | 0.06563309 |
| 128 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.05111615 |
| 129 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.03701620 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02831721 |

